FDA and Weight Loss
The FDA's approval of weight loss interventions is based on a flawed understanding of the relationship between weight and health, influenced by decades of research from the weight loss industry. Despite the promise of these drugs, evidence shows that weight regain is common once individuals stop taking them, and there are no guarantees of improved health outcomes. The narrative that thinner equals healthier lacks scientific backing and raises critical questions about the motivations behind promoting lifelong drug use for weight management.In this clip
From this podcast
Rethinking Wellness
The Dangers of Diet Drugs: Behind the GLP-1 Weight-Loss Hype with Ragen Chastain
Related Questions